2024-05-09T14:58:37-05:00 2023-12-31 330783700 PDM LLP 3460 TORRANCE BLVD STE 200 TORRANCE CA 90503 990 2023-01-01 264712664 OPEN MEDICINE FOUNDATION OPEN 6502428669 29302 LARO DRIVE AGOURA HILLS CA 91301 KIMBERLY HICKS COO/CFO/TREASURER 6502428669 2024-05-09 1 KIMBERLY HICKS 999009999 0 ANTHONY P BOZANIC CPA P01314417 3105404118 2 AAL1 IAL1 2023 2023-04-26 12:10:37Z KIMBERLY HICKS 29302 LARO DRIVE AGOURA HILLS CA 91301 6058625 0 X OMF.NGO X 2009 CA FUNDING COLLABORTIVE MEDICAL RESEARCH AND EDUCATION FOR MULTI-SYSTEM CHRONIC COMPLEX DISEASES. 8 6 6 6 0 0 3985928 5888844 0 0 -5686 173834 7568 -4053 3987810 6058625 5450094 4638675 0 0 910979 1089176 0 0 598154 475769 576251 6836842 6304102 -2849032 -245477 8684671 7790244 3809798 3160848 4874873 4629396 FUNDS COLLABORATIVE MEDICAL RESEARCH AND EDUCATION FOR MULTI-SYSTEM CHRONIC COMPLEX DISEASES. 0 0 5452667 4638675 THE ORGANIZATION SUPPORTS RESEARCH THROUGH 6 COLLABORATIVE RESEARCH CENTERS AND BY BRINGING TOGETHER A COMMUNITY OF "THOUGHT LEADERS," PATIENTS, CLINICIANS AND RESEARCHERS FOR TARGETED INITIATIVES. OPEN MEDICINE FOUNDATION IS CURRENTLY FOCUSED ON RESEARCHING MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME ("ME/CFS"), POST-TREATMENT LYME DISEASE, AND LONG COVID, IN HOPES OF ALSO REVEALING ANSWERS TO OTHER MULTI SYSTEM CHRONIC COMPLEX DISEASES THAT SHARE SIMILAR SYMPTOMS. ITS 4 PRIMARY GOALS ARE TO: 1).FRAME CLEAR DISEASE MECHANISMS AND MODELS. 2).FIND EFFECTIVE TREATMENT AND DIAGNOSTIC MARKERS. 3). INCREASE ACCURRATE DIAGNOSES. 4). ENSURE ACCESS TO QUALITY CARE. 5452667 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 27 0 6 1 0 0 0 0 0 0 0 0 0 0 X 8 6 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA CO CT DC FL GA IL KY MA MD MI MS NC NH NJ NM OH OK OR PA RI SC TN UT VA WA WI WV X X JITASA GROUP 2082874777 1750 W FRONT STREET BOISE ID 83702 LINDA TANNENBAUM CEO/PRESIDENT & PROGRAMS C 40.00 X X 290000 0 5000 KIMBERLY HICKS CFO/TREASURER & COO 40.00 X X 270000 0 5000 SHAI HELD BOARD OF DIRECTORS 5.00 X 0 0 0 DEBORAH ROSE BOARD OF DIRECTORS 5.00 X 0 0 0 HANY ZAYED BOARD OF DIRECTORS 5.00 X 0 0 0 VICKI SHULTZ BOARD OF DIRECTORS 5.00 X 0 0 0 DEBORAH GOULD BOARD OF DIRECTORS 5.00 X 0 0 0 CONNIE MINETT BOARD OF DIRECTORS 5.00 X 0 0 0 JILLIAN PAYNE CHIEF DEVELOPMENT OFFICER 40.00 X 215000 0 5000 775000 0 15000 3 0 1 0 REBECCA MORSEHEALTHFUL ENTERPRISES LLC 29302 LARO DR AGOURA HILLS CA 913011608 GLOBAL ORGANIZATIONAL OPERATIONS SUPPORT 167726 WENZHONG XIAO 40460 SEVILLE CT FREMONT CA 945393620 RESEARCH STIPEND FOR COMPUTATIONAL ANALY 150000 2 187710 5701134 294852 5888844 173834 173834 OTHER REVENUE 900099 -4053 -4053 -4053 6058625 -4053 0 173834 2165451 2165451 2473224 2473224 775000 304668 127406 342926 232327 91332 38194 102801 21312 8378 3504 9430 60537 23798 9952 26787 12412 9930 2482 60722 48578 12144 288084 212131 40651 35302 61766 30883 30883 18205 910 17295 46481 13944 9296 23241 67279 63915 3364 8542 8542 FUNDRAISING 6125 6125 WEBSITE 4927 4927 IN-KIND LABOR 1508 1508 TAXES AND LICENSES 200 200 6304102 5452667 253281 598154 5859973 4245423 358109 921079 1332448 20130 1134141 2603612 8684671 7790244 31101 17303 3778697 3143545 3809798 3160848 X 2095168 2388230 2779705 2241166 4874873 4629396 8684671 7790244 -245477 0 X X 0 1 X 1 0 X 4253049 4049835 5770635 3985928 5888844 23948291 4253049 4049835 5770635 3985928 5888844 23948291 1779911 22168380 33439 9037 39364 -5686 173834 249988 125 4098 17683 7568 -4053 25421 24223700 0.91520 0.75490 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 X 8327136 2268511 2268511 6058625 0 6058625 7291036 986934 986934 6304102 0 6304102 PART X, LINE 2: UNCERTAIN TAX POSITIONS FOOTNOTE PER AUDITED FINANCIAL STATEMENTS: IN ACCORDANCE WITH ACCOUNTING PRINCIPLES GENERALLY ACCEPTED IN THE UNITED STATES OF AMERICA, THE ORGANIZATION RECOGNIZES THE IMPACT OF TAX POSITIONS IN THE FINANCIAL STATEMENTS IF THAT POSITION IS MORE LIKELY THAN NOT OF BEING SUSTAINED IN AN AUDIT, BASED ON THE TECHNICAL MERITS OF THE POSITION. TO DATE, THE ORGANIZATION HAD NO TAX POSITIONS WHICH, IN THE OPINION OF MANAGEMENT, WILL BE REVERSED IF CHALLENGED BY A TAXING AUTHORITY. DURING THE YEAR, THE ORGANIZATION DID NOT RECOGNIZE ANY AMOUNT IN POTENTIAL INTEREST AND PENALTIES ASSOCIATED WITH UNCERTAIN TAX POSITIONS. PART XI, LINE 2D: CONSOLIDATED INDEPENDENT AUDITED FINANCIAL STATEMENTS INCLUDES: THE CANADIAN CORPORATION AND THE AUSTRALIAN LIMITED ENTITY. BOTH THE CANADIAN CORPORATION AND THE AUSTRALIAN LIMITED ENTITY SHARE TWO BOARD MEMBERS AND THE DEPENDENCY ON THE FOUNDATION FOR ITS BACK OFFICE AND ADMINISTRATIVE FUNCTION. PART XII, LINE 2D: CONSOLIDATED INDEPENDENT AUDITED FINANCIAL STATEMENTS INCLUDES: THE CANADIAN CORPORATION AND THE AUSTRALIAN LIMITED ENTITY. BOTH THE CANADIAN CORPORATION AND THE AUSTRALIAN LIMITED ENTITY SHARE TWO BOARD MEMBERS AND THE DEPENDENCY ON THE FOUNDATION FOR ITS BACK OFFICE AND ADMINISTRATIVE FUNCTION. 1 NORTH AMERICA GRANTS TO RECIPIENTS GRANTS FUND RESEARCH AND STUDIES FOR MULTI-SYSTEM CHRONIC COMPLEX DISEASES 617708 EUROPE (INCLUDING ICELAND & GREENLAND) GRANTS TO RECIPIENTS GRANTS FUND RESEARCH AND STUDIES FOR MULTI-SYSTEM CHRONIC COMPLEX DISEASES 1723126 EAST ASIA AND THE PACIFIC GRANTS TO RECIPIENTS GRANTS FUND RESEARCH AND STUDIES FOR MULTI-SYSTEM CHRONIC COMPLEX DISEASES 132390 0 0 0 0 0 0 2473224 0 2473224 EUROPE (INCLUDING ICELAND & GREENLAND) UPPSALA - CRC EQUIPMENT 13970 WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) PLRC - PATHOPHYSIOLOGY OF PEM 491494 WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) PLRC - FORAMINAL STENOSIS STUDY 300800 WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) PLRC - FIBRIN AMYLOID MICROCLOTS STUDY 354051 WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC NETWORK MEDICINE FOR ME/CFS 20029 WIRE TRANSFER 0 NORTH AMERICA PLRC - MOSAICS STUDY 617708 WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) DOMINO - ME 164576 WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) CHIEF MEDICAL OFFICER - STIPEND 140628 WIRE TRANSFER 0 EAST ASIA AND THE PACIFIC PLRC - MOSAICS STUDY 112361 WIRE TRANSFER 0 EUROPE (INCLUDING ICELAND & GREENLAND) PLRC - MOSAICS 257607 WIRE TRANSFER 0 0 10 0 0 0 0 0 0 PART I, LINE 2: ALL GRANTEES REQUESTING RESEARCH FUNDING FROM THE ORGANIZATION MUST DO SO UNDER AN APPROVED GRANT PROPOSAL. ALL GRANT PROPOSALS MUST BE APPROVED FIRST BY THE APPROPRIATE COLLABORATIVE RESEARCH CENTER DIRECTOR, AND THEN BY BOTH THE SCIENTIFIC ADVISORY BOARD EXECUTIVE COMMITTEE AND THE ORGANIZATION'S FULL FOUNDATION BOARD. ONCE THE GRANTS ARE APPROVED, THE ORGANIZATION'S COO/CFO/TREASURER WORKS WITH THE CEO/PRESIDENT, AND KEY CONTACTS AT THE GRANTEE'S INSTITUTION TO CONFIRM AND VALIDATE ALL GRANTEE INFORMATION. ONCE A PAYMENT SCHEDULE IS AGREED BY BOTH THE ORGANIZATION AND GRANTEE A GRANT AGREEMENT IS DISTRIBUTED FOR SIGNATURE ALONG WITH ALL RELEVANT PROJECT DOCUMENTATION. FUNDS ARE THEN DISBURSED ALONG WITH THE COUNTERSIGNED GRANT DOCUMENTATION, AND A LETTER OR EMAIL FROM THE ORGANIZATION CONFIRMING THE INTENDED USE OF THE FUNDS, AND A REQUEST FOR LETTER/EMAIL CONFIRMING RECEIPT OF FUNDS. ALL GRANTEES ARE REQUIRED TO PROVIDE REGULAR UPDATES TO THE ORGANIZATION'S CEO/PRESIDENT ON PROJECT STATUS, AND THE ORGANIZATION'S COO/CFO/TREASURER WORKS WITH KEY CONTACTS AT EACH RECIPIENT INSTITUTION TO RECEIVE FINANCIAL UPDATES. FOR ANY GRANTS REQUIRING PAYMENTS TO THIRD-PARTY RESEARCH LABORATORIES, THE ORGANIZATION'S COO/CFO/TREASURER WILL WORK WITH THE GRANTEE AND THEIR LABORATORY PARTNERS TO ESTABLISH PURCHASE ORDERS WITH APPROVED VENDOR QUOTES, UNDER WHICH FUTURE INVOICE PAYMENTS WILL BE MADE. ALL GRANT AND PURCHASE ORDER PAYMENTS ARE LOGGED AND TRACKED BY THE COO/CFO/TREASURER, AND RECONCILED ON A REGULAR, ONGOING BASIS. 1 BATEMAN HORNE CENTER 24 SOUTH 1100 EAST 205 SALT LAKE CITY UT 84102 870687610 501C3 300000 0 BHC CRC MEDICAL EDUCATION BETH ISRAEL DEACONESS MEDICAL CENTER INC 330 BROOKLINE AVENUE BOSTON MA 02215 042103881 501C3 487620 0 PLRC - SLEEP STUDY INSILICA LABS INC 428 MAYFIELD ROAD EASLEY SC 29642 270255856 10000 0 ITACONATE PROJECT JOSH WHITKIN CONSULTING 80 BAXLAND STREET HUNTERS HILL NSW AS 2110 540882406 13985 0 PERSONALIZED TREATMENT TRIAL APP SIMARON LLC 800 SOUTHWOOD BLVD 107 INCLINE VILLAGE NV 89451 880403942 120772 0 ME/CFS RESEARCH BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 485 BROADWAY REDWOOD CITY CA 940633136 941156365 501C3 54605 0 FAMILY OMICS STUDY TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER 3601 4TH STREET STOP 6271 LUBBOCK TX 79430 752668014 62182 0 PLRC- MOSAICS STUDY UCSF FOUNDATION 2001 THE EMBARCADERO 3RD FLOOR SAN FRANCISCO CA 94143 942829914 501C3 500000 0 PLRC - MONOCLONAL ANTIBODY TRIAL MASSACHUSETTS GENERAL HOSPITAL 38 SIDNEY STREET SUITE 161 CAMBRIDGE MA 02139 042697983 501C3 197688 0 PLRC - NETWORK MEDICINE STUDY WENZHONG XIAO 40460 SEVILLE CT FREMONT CA 94539 620740492 150000 0 COMPUTATION CRC RESEARCH STIPEND DAVID SYSTROM 17 GLENGARY ROAD WINCHESTER MA 01890 015481376 20000 0 HARVARD CRC RESEARCH STIPEND THE TRUSTEES OF BOSTON UNIVERSITY 715 ALBANY STREET BOSTON MA 02118 042103547 501C3 15526 0 PASS/CAT FINAL DELIVERABLES CALIFORNIA ADVANCED LABELING INC 46750 FREMONT BLVD SUITE106 FREMONT CA 94538 945386573 20723 0 PO GMMBH4-LC-CALTW FOR BH4 STUDY BRIGHAM & WOMEN'S HOSPITAL INC 38 SIDNEY STREET SUITE 161 CAMBRIDGE MA 02139 042312909 90805 0 POST EXTERTIONAL MALAISE MUSCLE BIOPSY STUDY EVIDENT SCIENTIFIC INC 48 WOERD AVENUE WALTHAM MA 02453 562538906 121434 0 NEUTROPHIL STUDY 6 15 X X 0 0 0 0 0 0 0 0 0 LINDA TANNENBAUM CEO/PRESIDENT & PROGRAMS C 290000 0 0 0 0 0 0 0 5000 0 295000 0 0 0 KIMBERLY HICKS CFO/TREASURER & COO 270000 0 0 0 0 0 0 0 5000 0 275000 0 0 0 JILLIAN PAYNE CHIEF DEVELOPMENT OFFICER 215000 0 0 0 0 0 0 0 5000 0 220000 0 0 0 X 1 294852 FAIR MARKET VALUE 0 0 0 FORM 990, PART VI, SECTION B, LINE 11B THE COO/CFO/TREASURER OBTAINS THE FINAL DRAFT OF THE FORM 990 FROM THE ORGANIZATON'S THIRD-PARTY 990 PREPARER AND REVIEWS. THE COO/CFO/TREASURER THEN DISTRIBUTES THE COPIES OF THE FORM 990 FINAL DRAFT TO THE BOARD. THE BOARD WILL REVIEW AND APPROVE THE FINAL FORM 990 BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C ANNUALLY, DURING BOD ELECTIONS, MEMBERS ARE ASKED TO SIGN THE CONFLICT OF INTEREST POLICY CONFIRMING THAT THEY UNDERSTAND THE POLICY AND ARE IN CONFORMITY WITH THE POLICY. ALL NEW STAFF AND BOARD MEMBERS ARE INFORMED OF THE POLICY AND ASKED IF THEY HAVE ANY CONFLICTS OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 ALL CHANGES IN MANAGEMENT COMPENSATION AND HIRING ARE APPROVED BY A VOTE OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICTS OF INTEREST POLICY, AND AUDITED FINANCIAL STATEMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART XII, LINE 2C: THERE HAVE BEEN NO CHANGES IN OVERSIGHT OR THE SELECTION PROCESS DURING THE YEAR.